[HTML][HTML] Therapeutic management options for stage III non-small cell lung cancer

SM Yoon, T Shaikh, M Hallman - World journal of clinical oncology, 2017 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer death worldwide. Majority of newly diagnosed
lung cancers are non-small cell lung cancer (NSCLC), of which up to half are considered …

21 years of biologically effective dose

JF Fowler - The British journal of radiology, 2010 - academic.oup.com
In 1989 the British Journal of Radiology published a review proposing the term biologically
effective dose (BED), based on linear quadratic cell survival in radiobiology. It aimed to …

Stereotactic body radiotherapy (SBRT) for operable stage I non–small-cell lung cancer: can SBRT be comparable to surgery?

H Onishi, H Shirato, Y Nagata, M Hiraoka… - International Journal of …, 2011 - Elsevier
PURPOSE: To review treatment outcomes for stereotactic body radiotherapy (SBRT) in
medically operable patients with Stage I non–small-cell lung cancer (NSCLC), using a …

Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy

Y Seppenwoolde, H Shirato, K Kitamura… - International Journal of …, 2002 - Elsevier
Purpose: In this work, three-dimensional (3D) motion of lung tumors during radiotherapy in
real time was investigated. Understanding the behavior of tumor motion in lung tissue to …

[HTML][HTML] Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi …

H Onishi, H Shirato, Y Nagata, M Hiraoka… - Journal of thoracic …, 2007 - Elsevier
Introduction Hypofractionated stereotactic radiotherapy (HypoFXSRT) has recently been
used for the treatment of small lung tumors. We retrospectively analyzed the treatment …

Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study

H Onishi, T Araki, H Shirato, Y Nagata, M Hiraoka… - Cancer, 2004 - Wiley Online Library
BACKGROUND Stereotactic irradiation (STI) has been actively performed using various
methods to achieve better local control of Stage I nonsmall cell lung carcinoma (NSCLC) in …

Hyperfractionated or accelerated radiotherapy in lung cancer: an individual patient data meta-analysis

A Mauguen, C Le Péchoux, MI Saunders… - Journal of clinical …, 2012 - ascopubs.org
Purpose In lung cancer, randomized trials assessing hyperfractionated or accelerated
radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or …

Image guidance for precise conformal radiotherapy

TR Mackie, J Kapatoes, K Ruchala, W Lu, C Wu… - International Journal of …, 2003 - Elsevier
PURPOSE: To review the state of the art in image-guided precision conformal radiotherapy
and to describe how helical tomotherapy compares with the image-guided practices being …

Stereotactic body radiation therapy of early-stage non–small-cell lung carcinoma: Phase I study

RC McGarry, L Papiez, M Williams, T Whitford… - International Journal of …, 2005 - Elsevier
Purpose: A Phase I dose escalation study of stereotactic body radiation therapy to assess
toxicity and local control rates for patients with medically inoperable Stage I lung cancer …

History of tomotherapy

TR Mackie - Physics in Medicine & Biology, 2006 - iopscience.iop.org
Tomotherapy is the delivery of intensity modulated radiation therapy using rotational delivery
of a fan beam in the manner of a CT scanner. In helical tomotherapy the couch and gantry …